II. Indications: Human Immunodeficiency Virus (HIV)
III. Dosing
- Pneumocystis Pneumonia Treatment
- Parenteral: 4 mg/kg/day IV or IM
-
Pneumocystis prophylaxis
- Nebulized (NebuPent): 300 mg nebulized every 4 weeks
IV. Adverse Reactions
- Neutropenia (15%)
- Thrombocytopenia
- Hypocalcemia
- Nephrotoxicity and Renal Insufficiency
- Hepatitis
- Pancreatitis
- Dysglycemia (20% treated for 3 weeks)
- Pentamidine causes pancreatic islet cell toxicity
- Hypoglycemia
- Hyperglycemia
- Gastrointestinal Upset (Nausea or Vomiting)
- Rash